The product is a generic version of Gilead Sciences Inc's Ranexa
extended-release tablets in the same strengths.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-gets-final-nod-from-usfda-for-angina-treatment-drug/articleshow/70141399.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment